Skip to content
Human Genome Context

Human Genome Context

Trustworthy Scientific Explanations

  • News
    • Research discoveries
    • Gene therapies
    • Biopharmaceuticals
    • Genomics sector
    • Machine learning in genomics
  • Diseases in the genome context
    • Cancer diseases
    • Mendelian diseases
    • Risk of diseases
  • Normal genomic traits
    • Human behavior
    • Human physical appearance
  • About
  • News
    • Research discoveries
    • Gene therapies
    • Biopharmaceuticals
    • Genomics sector
    • Machine learning in genomics
  • Diseases in the genome context
    • Cancer diseases
    • Mendelian diseases
    • Risk of diseases
  • Normal genomic traits
    • Human behavior
    • Human physical appearance
  • About

Category: Cancer diseases

  • Home
  • Diseases in the genome context
  • Cancer diseases
  • Cancer diseases
  • Visual Abstract

Cancer cells can survive fast mutation pace by a new mechanism: EMBR

Posted on January 10, 2019February 1, 2019

More: A stress response that allows highly mutated eukaryotic cells to survive and proliferate, R. A. Zabinsky et al., posted at bioRxiv 9th January 2019,…

Read More
  • Cancer diseases
  • Research discoveries

Novel method for detection of cancer driver mutations

Posted on December 8, 2018December 8, 2018

A new method of cancer genome analysis have led to identification of rare mutations contributing to cancer development. The main challenge of cancer genomics is…

Read More
  • Cancer diseases
  • Research discoveries

PCF11 is a critical regulator of neuroblastoma

Posted on November 26, 2018December 4, 2018

PCF11 gene regulates many pathways in neuroblastoma tissues by a process called alternative polyadenylation (APA). Brain tumors of infants and children are the most common…

Read More
  • Biopharmaceuticals
  • Cancer diseases

Liver cancer gains new immunotherapeutic biopharmaceutical: pembrolizumab

Posted on November 17, 2018November 18, 2018

Pembrolizumab, previously approved for various types of cancer diseases, has been approved for use in patients with hepatocellular carcinoma. Immunotherapies thrive in research initiatives and…

Read More
  • Cancer diseases
  • Research discoveries

oncRNA proposed – new molecules driving cancer

Posted on November 14, 2018

A new class of cancer-specific molecules has been identified and named as orphan noncoding RNA. Acronim oncRNA also relates them to potential oncogenic role. A…

Read More
  • Cancer diseases
  • Genomics sector

H3F3A mutations can be detected in bloodstream

Posted on November 5, 2018November 6, 2018

Pediatric patients with diffuse midline gliomas have acquired a new tool: non-invasive liquid biopsy detecting essential variantions of H3F3A gene. Histone genes (HIST1H3B/C, HIST2H3C, H3F3A)…

Read More
  • Cancer diseases
  • Research discoveries

BRAF-V600E mutations underlie long-term epilepsy-associated tumors (LEAT)

Posted on October 30, 2018November 16, 2018

Approximately half of brain cancer diseases with epilepsy symptoms may be associated with mutations in BRAF-V600E gene. A study found that 50% of 56 patients…

Read More
  • Cancer diseases
  • Research discoveries

Mutations leading to cancer can be detected even 10 years before disease

Posted on October 26, 2018October 29, 2018

Broad study of 2,658 patients, involving 39 types of cancer, has described mutations landscape. Cancer diseases on every stage are inevitably associated with genome mutations.…

Read More
  • Cancer diseases
  • Genomics sector

The largest catalogue of cancer mutations – COSMIC

Posted on October 24, 2018

A new version of COSMIC (Catalogue Of Somatic Mutations In Cancer) is available under https://cancer.sanger.ac.uk/cosmic. 2018 v86 relase of the catalogue describes 719 genes in…

Read More
  • Cancer diseases
  • Research discoveries

PRDM9 drives genomic instability in cancer

Posted on October 22, 2018

Gene PRDM9 have been associated with 32 various cancer types. One of the main hallmarks of cancer diseases is genome instability. It is global state…

Read More

Posts navigation

Previous

Recent Posts

  • The first successful gene drive in mammals – mice with Tyr gene January 31, 2019
  • Plant genome: new insights into methylation mechanisms January 28, 2019
  • UBE3A plays an important role in anti-viral immunity in the brain January 27, 2019
  • Details of novel rare USP7-associated neurodevelopmental disorder January 26, 2019

Who are we?

GenomeContext.com merges science communication with machine-learning driven analysis of scientific publications. Find out more in About section.

Tell us what we can improve

Contact Information

RafaƂ Grochala
Twitter: @Ivegot99introns
Mail: rafal(at)scicontext(dot)com

Project stage

This the second stage of the project (Q2). Most of current work is exploratory and experimental.

GenomeContext.com

The main purpose of GenomeContext.com is science communication, understandable for everyone. We provide original news reporting almost always based on scientific publications, sourced on the bottom.

 

Additionaly, GenomeContext.com is hands-on implementation of scientific analysis technology (SciContext.com), which guides and corrects devlopment process.

Copyright © 2019 Human Genome Context | All Rights Reserved